| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |